{{Rsnum
|rsid=2076602
|Gene=ATP13A2
|Chromosome=1
|position=16996703
|Orientation=minus
|GMAF=0.3085
|Gene_s=ATP13A2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 0.0 | 30.8 | 69.2
| HCB | 31.1 | 44.4 | 24.4
| JPT | 36.4 | 45.5 | 18.2
| YRI | 3.2 | 17.5 | 79.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 31.1 | 44.4 | 24.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22285144
|Title=ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}